» Articles » PMID: 32474093

COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2020 Jun 1
PMID 32474093
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since December 2019, when the virus was identified in humans, the literature on COVID-19 has grown exponentially and extrarespiratory symptoms including neurologic symptoms are increasingly highlighted.

Methods: Given the high and increasing number of publications reporting neurologic involvements of SARS-Cov-2, we thought that providing an update for neurologic complications of COVID-19 would be useful for physicians and especially young trainees in neurology and neurosurgery. Indeed, in this review we discuss several neurologic aspects reported in the literature to date including the evidence and pathways of neuroinvasion in COVID-19 and the main neurologic disorders reported in the literature to date, as well as future perspectives and the potential long-term consequence of current neuroinfection in COVID-19 patients.

Results: Currently, there is convincing evidence that SARS-CoV-2, the etiologic agent of COVID-19, can affect the nervous system, with damage and neurologic alterations. These neurologic disorders are grouped into several categories, ranging from nonspecific and moderate symptoms such as headache, myalgia, and hyposmia to severe symptoms including cerebrovascular disease and intracranial infections. Severe neurologic symptoms such as acute cerebrovascular disease occur only in a minority of patients with usual risk factors and are associated with poor outcome. However, most COVID-19 patients exhibit only minor or mild neurologic symptoms.

Conclusions: Management of COVID-19 patients should include early clinical, radiologic, and laboratory neurologic assessment, with a close follow-up, especially in severe forms. Future studies should assess late and long-term consequences of current COVID-19 patients with neurologic involvement.

Citing Articles

No lasting impact of Covid-19 on the auditory system: a prospective cohort study.

Hassani S, Lazem M, Jafari Z J Laryngol Otol. 2024; 135(12):1063-1068.

PMID: 39658938 PMC: 8576134. DOI: 10.1017/S002221512100267X.


Predicting stroke severity of patients using interpretable machine learning algorithms.

Sorayaie Azar A, Samimi T, Tavassoli G, Naemi A, Rahimi B, Hadianfard Z Eur J Med Res. 2024; 29(1):547.

PMID: 39538301 PMC: 11562860. DOI: 10.1186/s40001-024-02147-1.


Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation through the Retrospective Analysis of 152 Patients.

Colombo J, Weintraub M, Munoz R, Verma A, Ahmad G, Kaczmarski K NeuroSci. 2024; 3(2):300-310.

PMID: 39483361 PMC: 11523758. DOI: 10.3390/neurosci3020021.


Sudden Hearing Loss Waves: The Effect of COVID-19 Infection and Vaccination on the Inner Ear.

Tawk K, Tawk A, Abouzari M Adv Exp Med Biol. 2024; 1457:265-283.

PMID: 39283432 DOI: 10.1007/978-3-031-61939-7_15.


Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022.

Ferreira da Silva L, Alcantara L, Fonseca V, Frias D, Zardin M, Lichs G Viruses. 2024; 16(7).

PMID: 39066305 PMC: 11281713. DOI: 10.3390/v16071143.


References
1.
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

2.
Dobbs M . Toxic encephalopathy. Semin Neurol. 2011; 31(2):184-93. DOI: 10.1055/s-0031-1277989. View

3.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

4.
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View

5.
Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View